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Abstract. Dosage forms with increased gastric residence time are promising tools to
increase bioavailability of drugs with narrow absorption window. Low-density ﬂoating
formulations could avoid gastric emptying; therefore, sustained drug release can be achieved.
Our aim was to develop a new technology to produce low-density ﬂoating formulations by
melt foaming. Excipients were selected carefully, with the criteria of low gastric irritation,
melting range below 70°C and well-known use in oral drug formulations. PEG 4000, Labrasol
and stearic acid type 50 were used to create metronidazole dispersion which was foamed by
air on atmospheric pressure using in-house developed apparatus at 53°C. Stearic acid was
necessary to improve the foamability of the molten dispersion. Additionally, it reduced
matrix erosion, thus prolonging drug dissolution and preserving hardness of the moulded
foam. Labrasol as a liquid solubiliser can be used to increase drug release rate and drug
solubility. Based on the SEM images, metronidazole in the molten foam remained in
crystalline form. MicroCT scans with the electron microscopic images revealed that the foam
has a closed-cell structure, where spherical voids have smooth inner wall, they are randomly
dispersed, while adjacent voids often interconnected with each other. Drug release from all
compositions followed Korsmeyer-Peppas kinetic model. Erosion of the matrix was the main
mechanism of the release of metronidazole. Texture analysis conﬁrmed that stearic acid plays
a key role in preserving the integrity of the matrix during dissolution in acidic buffer. The
technology creates low density and solid matrix system with micronsized air-ﬁlled voids.
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INTRODUCTION
Several drugs display site-speciﬁc absorption in the
gastrointestinal tract (1). Contribution of numerous factors,
such as site speciﬁc, environmental pH and/or intestinal
enzyme activity, could lead to low bioavailability (2). The
gastrointestinal motility determines the residence time of the
formulation in its absorption window (3).
Gastric retention is a promising mechanism for the oral
modiﬁed-release drug products (4). These delivery systems
provide sustained drug release coupled with resistance against
the gastric milling (5,6) and emptying motions (7,8) and show
prolonged residence time in the stomach. On the other hand,
when localised therapy of the stomach or the duodenum is
preferred, these delivery platforms may provide site-speciﬁc
drug release for a longer time (9).
To achieve gastric retention, several technologies are
available. Expanding devices increases their size upon or
followed by the contact with gastric juice to inhibit transit
through the pyloric sphincter. Hydrogels (5,10), and other
unfolding technologies, such as the Accordion Pill® (7,11,12),
are formulations with prolonged residence time in the
stomach. Mucoadhesive formulations containing hydrophilic
polymers adhere to the gastric mucosa (13) and release their
drug in sustained manner.
Floating or low-density formulations remain on the top
of the gastric content (14), thus avoiding passage to the
duodenum. Gas-generating platforms usually contain carbon-
ates (15–17) and polymers to entrap the formed gas or a
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balloon ﬁlled with volatile liquid. Nevertheless, the ﬂoating
lag time, the time needed for the formulation to rise to the
surface, might take a couple of minutes in some cases (18).
Instantly ﬂoatable devices, on the other hand, have no lag
time, they remain on the surface (9,19–21).
Up to date, promising new platforms and technologies to
produce low density and sustained release formulations were
developed. Hot-melt extrusion was successfully used to inﬂate
extrudates with ethanol (9), carbonates (22,23) or pressurised
carbon dioxide (24) . However, these processes were done at
high temperature and the cutting or spheronisation was done
after ﬁlament extrusion.
Our aim was to develop a simple and new technology,
based on melt-foaming, which can be easily ﬁlled into the
ﬁnal dosage form, namely hard gel capsules. After ﬁlling, the
foam quickly solidiﬁes upon cooling and keeps its structure.
In this work, a novel apparatus is presented and detailed for
foaming a molten dispersion by mechanically dispersing gas
into it. The main pharmaceutical attributes of the ﬂoating
solid foams are also described.
MATERIALS AND METHODS
Materials
Polyethylene glycol 4000 (PEG4000), stearic acid, type
50 (SA) and metronidazole (MNZ) were Ph. Eur. grade and
purchased from Molar Chemicals Ltd. (Halásztelek, Hun-
gary). Labrasol® was kindly gifted from Gattefossé (Saint-
Priest, France). Other reagents were all of analytical grade
and purchased from Sigma Aldrich Kft. (Budapest, Hungary).
Foaming Device Setup
In-house apparatus was designed and built from poly-
propylene tube. The equipment is presented in Fig. 1. Brieﬂy,
the apparatus is a cylinder with the volume of 60 mL, which
ends at the bottom in a 10-mm wide valve. The outer surface
on the sides and at the bottom is water-jacketed with 6-mm
plastic tubing. The jacket is connected to a Julabo F25
temperature control unit equipped with a Julabo ME
circulator. The agitator is made of 1-mm wide stainless steel
wires. The agitator is connected to an IKA EURO-ST D
overhead stirrer. Dimensions and a schematic picture of the
agitator are also presented in Fig. 1.
Effect of Temperature on the Viscosity of the Molten
Suspension
The apparent viscosity of the molten PEG4000 contain-
ing 30 m/m% MNZ was measured by a Rheolab QC
rheometer (Anton Paar Hungary Ltd.) equipped with a
concentric cylinder-jacketed measuring cell. The cell was
connected to a Viscoterm VT 2 waterbath (Anton Paar
Hungary Ltd.). The viscosity curves were recorded with the
RheoPlus software. The measurement cell was heated to
65°C prior to loading with the molten and homogenous MNZ
suspension. Viscosities were measured between 65 and 53°C
with the difference of 2°C with constant shear rate of
1000 rpm. The maximum viscosity values were plotted as a
function of temperature.
Preparation of Solid Foams
Forty grams of the different compositions (M1-M7),
presented in Table I, was foamed by the following method.
PEG 4000, Labrasol® and SA were measured and loaded
into the preheated foaming equipment with the slow agitation
of 50 rpm at 65°C (jacket temperature). After complete
melting, MNZ (average particle diameter, 180–125 μm) was
dispersed for 10 min in the molten mixture, at 300 rpm.
Cooling was started by setting the temperature of the water
circulating in the jacket to 53°C. After 5 min, when the
temperature of the water reached 53°C, foaming was done by
heavy agitation at 2000 rpm and dispersing air into the molten
mass. The procedure was done for 5 min maximum. For
further investigations of the foamed matrix system, the
foamed and hot dispersion was moulded into a steel mould
(V = 1.027 mL, bullet shape) and cooled.
Determination of the Densities of the Samples
The following method was used to determine the density
of the moulded compositions, (unfoamed or foamed) based
on the pycnometer method. Firstly, liquid parafﬁn was ﬁlled
into a 100-mL volumetric ﬂask, up to the graduation marking.
The ﬁlling weight was precisely measured and the true
density of liquid parafﬁn was calculated. The value of density
was found to be 0.857 g/mL. The cavities of the steel mould
were fully ﬁlled with pure PEG 4000. After scraping off the
excess amount, the solid blocks were removed from the
mould and their weights were recorded. Later, a sample was
loaded into a 100-mL volumetric ﬂask and appropriate
Fig. 1. In-house apparatus with a whisker-type agitator used for
melting, mixing, foaming and moulding the dispersion (3.0 × 10.0
diameter, height in centimetres, the difference between the shaft and
the whisker head is 8.0 cm)
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amount liquid parafﬁn was added to ﬁll the ﬂask up to
100 mL. The volume of each sample was determined with the
following formula:
Vs ¼ mp1−mp2ρ
where Vs is the volume of the sample, mp1 is the weight of
liquid parafﬁn which ﬁlls up the ﬂask without an immersed
sample, mp2 is the weight of liquid parafﬁn which ﬁlls up the
ﬂask with an immersed sample; ρ is the density of the liquid
parafﬁn. Using the mass and volume data of the samples,
their densities were calculated.
SEM Analysis and Diameter Determination of Foam Cavities
Hitachi Tabletop microscope (TM3030 Plus) was used to
characterise the solid foams (22). Samples were split in halves
and were attached to a ﬁxture with a double-sided adhesive
tape containing graphite. Average diameter of the voids was
calculated by measuring the diameter of hundred random
cavities (GIMP 2.8 software) from at least 3 regions of the
solid block.
Microtomography
In order to characterise and visualise the internal
microstructure of solidiﬁed molten foamed and unfoamed
dispersion of M7 samples, the following protocol was
developed. As described in ‘Preparation of Solid Foams’
section, the regular foaming process was done. A small
portion of the homogenous dispersion was removed prior to
the foaming step, from the jacketed vessel with a PET tube
(internal diameter, 5.0 mm) attached to a 10-mL syringe, to
obtain the unfoamed sample. After the foaming step, another
portion was quickly and carefully removed from the vessel
with a similar PET tube to prepare the foamed sample. The
molten dispersions were allowed to cool down and solidify in
the plastic tubes. After solidiﬁcation, the rods of the solid
samples were cut into 5–6-mm long cylinders. A random
foamed and unfoamed cylinder was attached to each other
with a soft glue and this preparation was scanned later. A
SkyScan 1272 compact desktop microCT system was used for
the measurement. Scanning parameters were the following:
image pixel size, 5 μm; matrix size, 1344 × 2016 (rows ×
columns); source voltage = 50 kV; source current = 200 μA;
ﬂat ﬁeld correction and geometrical correction were used.
After scanning, SkyScan NRecon package (Version:
2.0.4.2) was used to reconstruct cross-section images from
tomography projection images. Post-alignment, Beam-
hardening correction, Ring artefact correction and Smooth-
ing were done. The output formats were DICOM and
BPM images.
Dissolution Test
Nine hundred milliliters of hydrochloric acid media, pH:
1.2 without pepsin was selected for dissolution tests (16,25).
Rotating paddle method with the rotation speed of 75 rpm
and 37°C was set up in a dissolution tester (Erweka DT 800).
Samples of 4 mL were withdrawn after 5 min, 15 min, 30 min,
1, 2, 3, 4, 5, 6, 7, 8 and 10 h. The samples were diluted with
puriﬁed water and ﬁltered through a 0.22-μm PES membrane
syringe ﬁlter. The released amount of MNZ was determined
by UV/VIS spectrophotometer (Shimadzu UV 1601,
Shimadzu Corp. Kyoto, Japan) at 278 nm. Three random
samples were selected for the tests from every composition.
Floatation was inspected at the beginning, during and at the
end of the test also.
Water Uptake and Matrix Erosion Studies
Erosion and swelling properties of the solid formulations
were determined by the following method. The initial weights
of the samples (Wini) were recorded before the experiment,
then they were placed into the dissolution vessels as described
in the ‘Dissolution Test’ section. After 1, 3, 5, 7 and 10 h,
samples were carefully removed with a plastic net and the
weight of the wet samples (Wwet) was measured after blotting
the excess water. The samples were then dried in an oven
(Memmert SFE 550, Memmert GmbH, Germany) at 45°C for
48 h, after cooling to room temperature, their constant weight
(Wdry) was measured (18). Three samples were tested from
all compositions.
Water uptake % (WU %) was calculated by the
following formula: (26)
%WU ¼ Wwet−Wdry
Wwet
 100
Table I. Compositions and Densities of the Foamed Compositions
Formulation MNZ SA PEG 4000 Labrasol Density (g/cm3) ± SD
before foaminga
Density (g/cm3) ± SD
after foaminga
M1 30% 0% 70% 0% 1.28 ± 0.0072 1.26 ± 0.0102
M2 30% 0% 68.5% 1.5% 1.27 ± 0.0073 1.14 ± 0.0195
M3 30% 0% 67.5% 2.5% 1.22 ± 0.0284 1.17 ± 0.0144
M4 30% 5% 63.5% 1.5% 1.22 ± 0.0178 0.89 ± 0.0341
M5 30% 10% 57.5% 2.5% 1.26 ± 0.0098 0.93 ± 0.0396
M6 30% 5% 65% 0% 1.27 ± 0.0093 0.82 ± 0.0261
M7 30% 10% 60% 0% 1.29 ± 0.0083 0.93 ± 0.0408
Prior to density determination tests, randomly selected samples from the solidiﬁed and moulded compositions were tested to conﬁrm instant
ﬂoatation in pH 1.2 acidic buffer. M1, M2 and M3 compositions failed on this preliminary test, and their densities were determined to be more
than 1.00 g/cm3
aData present average values and standard deviations (n = 15)
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Matrix erosion % and remaining masses of the foams
were determined with the following formulas (27):
%Erosion
W ini−Wdry
W ini
 100
%Remaining ¼ 100%−Erosion%
whereWwet means the weight of the wet samples,Wdry means
the dried weight of the samples and Wini means the initial
weight of the samples, before test.
Mathematical Analysis of the Drug Release Profiles
To compare the dissolution data of the different compo-
sitions, similarity or difference factors were calculated, as a
model independent approach: similarity, f2 and difference, f1
factor was calculated for each composition. Dissolution
efﬁcacies were also calculated (28).
f1 ¼ ∑
n
j¼1jRj−T jj
∑nj¼1Rj
 100
where n is the sampling number, Rj and Tj are the percent
dissolved of the reference and the test products at each time
point j.
f2 ¼ 50 log 1þ 1=nð Þ∑nj¼1wj Rj−T j




2
h i−0;5
 100
 
where wj is an optional weight factor.
DE ¼ ∫
t
0y dt
y100  t
 100%
where y is the drug percent dissolved at time t.
For the determination of release kinetics of MNZ,
release data was ﬁtted to zero-order, ﬁrst-order and
Korsmeyer-Peppas model equations.
Q ¼ Q0 þ k0t
Qt ¼ Q0  e−k1t
Qt
Q∞
¼ kkptn
where Q is amount of drug release at time t, Q0 is the initial
amount of drug, Qt is the amount of drug remaining at time t,
and where Qt/Q∞ is fraction of drug released at time t. k0, k1
and kkp are the kinetic constants for zero-order, ﬁrst-order
and Korsmeyer-Peppas models, respectively and n is the
release exponent, indicative of the drug release mechanism.
For Korsmeyer-Peppas model, only release data points were
used in the analysis up to 60% drug release (29) .
Statistical Analysis
For statistical analysis, GraphPad Prism® (Version 6.01,
GraphPad Software Inc.) was used. Unpaired t tests were
performed when two groups were compared, and one-way
ANOVA was chosen when comparison of multiple groups
was performed. Differences were considered signiﬁcant at
p < 0.05 (28).
Dissolution Coupled Texture Analysis
Texture analysis was chosen to characterise the mechan-
ical properties and structure of the dry and wetted foamed
compositions. Dry samples were tested at 25°C without
immersing them into acidic dissolution media. To monitor
and determine hardness changes and erosion of the ﬂoating
formulations, three random samples were placed onto
dissolution vessels containing 900 mL of 37°C pH 1.2
hydrochloric acid media with 75-rpm paddle speed. To
visualise water permeation into the matrix, the media was
coloured with 20 drops of 5 m/m% Sicovit® Tartrazine
(BASF) solution. The samples were carefully removed after
1, 3, 5, 7 and 10 h later and excess water was removed by
using soft and plastic net and tissues. Wet and dry samples
were analysed by the following method. Brookﬁeld CT3
texture analyser was equipped with an acrylic cylinder,
TA25/1000, (d: 50.8 mm) and the device was programmed
to compress the blocks with constant speed (0.50 mm/s) until
4500 g of load. At the target pressure, the device ﬁxed the
probe for 5 s as a hold time. Following the hold time, the
probe returned to its initial position; thus, the measurement
took 20 s per sample. The load values were plotted in the
function of time (s) to present the changes in the texture in
real time.
RESULTS
Effect of Temperature on the Viscosity of the Molten
Suspension
Due to the polymeric nature of the PEG 4000 and to
enhance the efﬁcacy of gas entrapment in the molten
dispersion, it was a key point to determine the viscosity-
temperature relationship of the compositions. It is known that
PEG 4000 has a melting point around 58–59°C (30,31). On
the other hand, according to the speciﬁcation of the
European Pharmacopoeia, the freezing range is between 53
and 59°C. The effect of the MNZ on the viscosity changes of
the solidiﬁcation process was determined and the results are
presented in Fig. 2. Fifty-three degree Celsius was found to
show the highest viscosity values, namely 0.994 (Pa s), which
was suitable for mixing. It was also noticed that during the
precise cooling, the viscosity values increased as the molten
dispersion became semi-solid from its liquid state. As an
optimal temperature to maximise gas entrapment efﬁcacy,
53°C was chosen and later foam production was done at this
temperature.
Density Values of the Foamed Compositions
The density values and the average weights of the
dispersions before and after foaming are also presented in
Table I. It was found that M1, M2 and M3 are non-ﬂoating
compositions, because their density results are higher than
1 g/mL. These compositions were excluded from further
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investigations. M4, M5, M6 and M7 were successfully foamed
with this technology as their density values were below 1 g/
mL and as a result, all of the foamed M4, M5, M6 and M7
compositions showed zero ﬂoating lag time in puriﬁed water.
As a result of the foaming, the values of standard deviations
increased as shown in Table I. The lowest density reached
was 0.82 g/mL, this belongs to the M6 formulation. This
means a 35.6% decrease in the mass, due to the dispersed gas.
The average calculated API content in this formulation was
found to be 252.3 mg.
SEM Analysis and Void Characteristics
On the SEM images (Fig. 3), the cavities created in themelt
by the dispersed gas phase can be easily distinguished from the
matrix of the solidiﬁedmelt and the crystals of theMNZ are also
detectable. Owing to dispersing air into the molten material, the
shape of the cavities is typically spherical or spheroidal. Cavities
formed by the merging of bubbles may also be present. The
cavities formed by merging of bubbles have short channel-like
appearance, and they are assumed to originate from mechani-
cally dispersing gas in the melt. The inner surfaces of the cavities
are typically smooth, uneven surface can possibly be seen as
well, as a result of the solidiﬁed but once ﬂuid melt. The
solidiﬁed melt forms one single phase in which the solid,
undissolved crystals of the MNZ are present and the cavities
created by the dispersed gas are distributed randomly. Particles
of MNZ can be easily distinguished from the melted and
solidiﬁed carrier and from the cavities created by the dispersed
gas. It is not typical that any of the interfaces in the melt is
enriched in solid particles. Scanning electron microscopy
conﬁrmed the development of a closed cell foam structure in
the case of all foamed compositions. The structure of the foam is
homogeneous and the smooth outer surface does not form a
shell. The sizes of the voids were found to be 254 ± 83, 193 ± 63,
231 ± 113 and 67 ± 25 μm for M4; M5; M6 and M7, respectively.
Microtomography Results
Figure 4 shows the reconstructed image of the microCT
scans performed on M7 composition. It is clearly seen that the
Fig. 2. Viscosity temperature curve of the 30 m/m%MNZ- PEG 4000
suspension
Fig. 3. Representative SEM pictures of the M4 (a), M5 (b), M6 (c) and M7 (d) solid foams.
Magniﬁcations are between × 18 and × 30. Red arrows indicate the solid particles of MNZ in the
solid foams
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process phase of MNZ dispersion incorporates tiny air
bubbles into the molten dispersion which form voids in the
molten matrix thereafter. On the other hand, the foaming
process step creates a highly porous structure where the
molten matrix is loaded with spherical or spheroidal bubbles.
The distribution of the bubbles or voids is random. The
reconstructed and computed model of the foam structure
shows a closed cell structure in which interconnecting voids or
deformed bubbles are present. These short channel-like voids
could show various shapes, but most of them can be imagined
as few chambers or rooms interconnected with tubular
passages. However, none of them were found to be opened
to the outer environment.
Dissolution and Floating Properties
During the dissolution tests, all samples were proven to
possess zero ﬂoating lag time and none of them sank before
complete disintegration. In the case of completely
disintegrated M4 compositions, raft-like remnants were
present at the top of the aqueous media. Dissolution
properties (dissolution proﬁle, results of the water uptake
studies along with the erosion of the formulations) are
presented in Fig. 5. M4 was found to release the MNZ in
the shortest time, namely 91.07% were dissolved until 3 h.
Water uptake curve of M4 greatly differs from the others. It
was observed that the percentage of the water uptake of this
formulation increased until 1 h, then a maximum uptake was
reached at 3 h. At this time point, one of the samples
completely eroded, and only two were removed and tested.
The average of the percentage of remaining mass of the
samples is only 6.56%. After 7 h, complete disintegration of
the foamed matrix of M4 occurred. M5 released 88.33% of
the drug after 5 h. Regarding its water uptakes and erosion,
only 15.16% of the original mass of M5 was found in the
dissolution media, with absorbing 68.97% water from the
dissolution buffer. Water uptake maximums were found at
10 h, namely 82.16%, 86.95% and 69.94% for M5, M6 and
Fig. 4. a Reconstructed microCT image of the M7 composition. The
upper block represents the foamed product with a section from the
original images, while the lower block represents the unfoamed
product with a section from the original images. b Reconstructed
model of the foamed melt presenting a closed-cell structure with
interconnecting voids
Fig. 5. a Dissolution proﬁles of the ﬂoating foamed compositions.
Bars represent mean ± S.D. (n = 3). b Water uptake (%) vs. time (h)
curves of the ﬂoating foamed compositions. Bars represent mean ±
S.D. (n = 3). c Erosion of the ﬂoating foamed compositions. Bars
represent mean ± S.D. (n = 3)
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M7, respectively. M6 released only 83.27% at 5 h, at that time
point, 29.13% of the average initial weight was present in the
dissolution vessel. Water uptake of the M6 samples continu-
ously increased by time until the end of the test. M7 was
found to release only 85.79% its MNZ content at 10 h. M7
adsorbed the least amount of water during this test and
showed that the average of 26.92% mass remained after 10 h.
Drug Release Analysis and Model Fitting
Dissolution efﬁciencies were calculated for each ﬂoating
compositions and are presented along with the results of the
pairwise procedure analysis in Table II. Comparison of the
release proﬁles revealed that the drug release from M5 and
M6 can be considered similar only (f1 and f2 are 4.92 and
67.87, respectively). When the dissolution efﬁciencies were
calculated, it was found that for M4 showed the fastest release
with the value of 88.43%, while for M7, the value of DE was
only 57.21%.
Drug release data were ﬁtted to zero-order, ﬁrst-order
and Korsmeyer-Peppas models (Table III). Determination
coefﬁcients were used to determine the best ﬁt. None of the
models ﬁtted to zero-order model, while the calculations
revealed that the release data of all presented formulations
ﬁtted best to the Korsmeyer-Peppas model, since the
correlation coefﬁcients were all greater than 0.99.
Texture Analysis
Figure 6 represents the results of the texture analysis. It
was revealed that in the cases of all ﬂoating compositions, a
hard and resistant structure is present in spite of the air
entrapment. Applying 4500 g of compression load on the
foams did not result any cracks or fractures in the dry state at
25°C. On the other hand, when the compositions were
compared, it was found that the deformation of M4 under
the constant pressure of the analyser probe for 5 s is
signiﬁcantly different that the others, p < 0.0001. Regarding
M4, a softer structure was found. As was expected on the
basis of the erosion studies, M4 samples could be tested at
only 1 h. M4 samples presented small dry and resistant cores
inside, the compression of this core resulted a sharp drop in
the load values, as seen on the diagram at 6.54 s (Fig. 6b).
Those inner cores in the three parallel samples were small
and fragile enough to be compressed and ﬂattened by the
moving probe. M5, M6 and M7 still contained dry, solid cores
inside also, but their resistance against the compression force
was different. When the M5 samples were tested, two of them
contained dry cores resistant to the compression force, but
one of them contained a fragile core inside which collapsed
under the pressure of 3609 g and a series of smaller collapses
took place until a more compacted structure developed to
stop the measurement probe. M6 showed an outer pliable and
deformable jacket-like outer part, compared with M7. M7
however presented a wetted outer layer which separated duo
to the compressional test (Fig. 6d). After 3 h, all samples of
M5, M6 and M7 were compressed and somewhat ﬂattened by
the measurement probe. M5 samples showed fragile inner
cores which collapsed with a series of smaller collapses upon
compression. The upslope of the curve starts at earlier time
point, namely at 6.84 s indicating that the M5 compared with
M6 (upslope starts at 8.92 s) and M7 has a softer structure.
M7 at this time point also showed a more solid structure,
since the load values are higher even at early time points,
from 2 to 7 s. On the other hand, as represented with a photo
on Fig. 6d, M7 lost a much of its integrity compared with the
1-h measurement. After 5 h, M7 contained only dry and
brittle core, and from 2 to 11 s of the test time, higher load
values were recorded. After 7 h, a nearly complete wetting
and erosion of the samples resulted similar load-time curves
for M5, M6 and M7. The only difference was found in the
time coordinates of the turning points, namely 9.30, 10.18 and
12.20 for M5, M6 and M7, respectively.
DISCUSSION
Our aim in this study was to design, build and use a batch
type in-house apparatus to produce lipid-based monolithic
matrices. We created low density, sustained release formula-
tions with instant ﬂoating properties in acidic buffer without
the need of gas generation and entrapment. After foaming,
the formulation can be easily ﬁlled into the ﬁnal dosage form,
hard gel capsules, and then the foam quickly solidiﬁes upon
cooling and keeps its structure resulting the ﬂoating
properties.
For the selection of the appropriate materials, we
considered the following. The main matrix component must
be solid at body temperature; therefore, it should possess
mechanical resistance against the churning movements of the
gastric contraction waves, because early matrix disintegration
will lead to faster drug release (32). On the other hand, it
should melt below 70°C, this temperature is a key factor. This
temperature is the maximum ﬁlling temperature of hard
gelatine capsules. At lower temperature, no risk of capsule
Table II. Release Proﬁle Comparison and Dissolution Efﬁciencies of
the Floating Formulations
Dissolution efﬁciencies Pair-wise comparison of dissolution proﬁles
f1a f2b
M4 vs M5 11.11 47.28
M4 vs M6 15.48 41.06
M4 88.43% M4 vs M7 36.88 25.84
M5 79.84% M5 vs M6 4.92 67.87
M6 76.04% M5 vs M7 28.99 33.92
M7 57.21% M6 vs M7 25.32 38.02
a f1 values of the difference factor calculation
b f2 values of the similarity factor calculation
Table III. Model Fitting Results of the Dissolution Data
Composition Zero-order First-order Korsmeyer-Peppas
M4 0.7038 0.9875 0.9932
M5 0.7148 0.9479 0.9967
M6 0.7790 0.9836 0.9989
M7 0.8324 0.9947 0.9985
All values represent determination coefﬁcients for each model
ﬁttings. Italic numbers indicate the highest values for each
composition
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shell damage (33) can occur and this attribute provides the
possibility that the foamed dispersion can be ﬁlled into two-
piece hard gel capsules. During our study, we applied a steel
mould to study the foamed matrices and to discover its main
pharmacological and physicochemical properties. The volume
of each cavity in the mould (1.027 mL) and their dimensions
are comparable with size 00 hard capsule (0.91 mL).
Gastroretentive formulations must remain in the stomach to
gradually release the API, which can be absorbed through the
proximal part of the small intestine later (2,9). However,
accumulation of the empty carriers should not happen;
therefore, degradability or gradual disintegration (34) must
be integrated into the matrix by careful design. PEGs, for
instance PEG 4000, are a polymer with high degree of
solubility in water and a melting range below 60°C. It is also
favourable from technological aspect that it can exist in semi-
solid state also, in which state, due to the high viscosity (35),
dispersing gas into the ﬂuid dispersion leads to a more
efﬁcient foam formation. Optimal temperature with sufﬁcient
ability to be moulded and to entrap gas was found for this
polymer at 53°C.
In this study, we demonstrate that four different compo-
sitions with zero ﬂoating lag time were prepared with our
apparatus in batch mode by ﬁlling the foamed and hot
dispersions into metal mould. Labrasol for our experiments
were selected as a non-ionic oil-in-water surfactant. In spite of
its HLB value of 14, it has a decreased cytotoxicity compared
with Polysorbates (36). It is well known as a solubiliser and o/
w surfactant. It can be used for microemulsions and it is able
to form light foams, as well (37). Based on our result, we can
state that to sufﬁciently decrease the density of the disper-
sions, at least 5% SAwas also elementary, 1.5% or 2.5 m/m%
Labrasol alone could not decrease the densities below the
density limit of 1.00 g/mL. However, we do not exclude the
possibility that with increased agitation speed and shear force
coupled with controlled gas injection, PEG-API gas disper-
sions can be created. Our apparatus disperse air at atmo-
spheric pressure into the molten dispersion by cavitation and
by vortex formation. During operation the wires of the
agitator leaving and splashing into the swirling dispersion
(38), this mechanism sucks and pulls air into the liquid in
motion by breaking up the gas/liquid interface and also cause
breakup of the previously dispersed bubbles. Addition of 5 m/
m% SA to the PEG-MNZ dispersion decreased the density to
the average value of 0.82 g/mL. This was a surprising and an
unexpected result for us, which highlighted the importance of
this material. The HLB value of the SA is 15 (39).
Besides its numerous application as a dissolution retar-
dant (40) in oral hydrophobic matrix systems, SA when
neutralised with tetrabutylammonium hydroxide can be used
to create foam from o/w emulsions (41). The authors states
based on the results of the experiments that SA contributes to
the easier foamability due to two of its property. Firstly, SA,
type 50 contains not only pure C18 fatty acid, this type of the
excipient should contain at least 40.0–60.0% stearic acid, and
the sum of the stearic acid and palmitic acid content must be
at least 90.0%. The palmitic acid content results a lower
melting temperature range, namely between 53 and 59°C
compared with the pure SA, melting point, 69.6°C (39,42).
This contributes to an increased viscosity at 53°C. Secondly,
Fig. 6. a Texture analysis result of the dry, foamed compositions at 25°C and dissolution coupled texture analysis result of the immersed samples
at 37°C after 1 h (b), 3 h (c), 5 h (e), 7 h (f), 10 h (g). d Representative photos of M7 solid foams after compression by the measurement probe
(from left to right: 1, 3, 5, 7 and 10 h), yellow stain was added into the dissolution media to follow the water permeation into the sample
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the presence of C18 and C16 fatty acids in the PEG matrix
could also stabilise the air/PEG interface by accumulating at
the surface of the air bubbles, thus creating an apolar layer
which surrounds the dispersed gas phase. Similar mechanism
has been earlier described and discussed when diary emulsion
was foamed with a similar whipping technique (43,44). This
hypothesis however should be conﬁrmed by upcoming
experiments.
The stabilization of the air/PEG interface can be detected
when surface analysis was performed, adding SA alone results
air bubbles in micron scale, while combining Labrasol with SA
results an increase in the void sizes. On the other hand, open-cell
structures were not created, but short and interconnecting
clusters of spherical voids developed in all cases. None of the
pictures showed that the dispersed crystals of MNZ were
involved in bubble entrapment of interphase stabilisation, this
is in concordance with the data of M1 composition presented in
Table I. MicroCT scans on M7 foam structure conﬁrmed a
presence of a complex spongy structure. The foam structure
however is not surrounded by a hard and thick, bubble-free
shell-layer or outer jacket. Air was randomly distributed
throughout the whole matrix. Signs of bubble coalescence, on
the other hand, were detected. It can be stated on the basis of
the results of imaging techniques, on Fig. 3 a, b and c, the
interconnections are clearly seen on SEM pictures, while
microCT scan of M7 conﬁrmed the same structure with smaller
voids (Fig. 4). SEM pictures also conﬁrmed that MNZ remained
in its crystalline form. Additionally, MNZ melts at 162.32°C
(28), and no solid solution was prepared.
When the foamed compositions were investigated regarding
their release characteristics, we found that the Labrasol
increased the erosion and dissolution rates due to its good ability
of micelle solubilisation (36). Regarding the water uptake
studies, the PEG matrix absorbs water and swelling of the
polymer chains develops; however, we should also mention that
water can also penetrate and ﬁll up the micronsized cavities. On
the other hand, the whole inner pore system could not be
completely ﬂooded due to the shortness of the interconnections.
This is favourable, since gas is entrapped in separate chambers
providing continuous ﬂoatation. Dissolution of MNZ when
compared with the matrix erosion curve suggests that drug
release is mainly controlled by erosion. It can be stated on the
basis of the presence of MNZ crystals and the low solubility of
MNZ inwater (45). On the one hand, it is noteworthy tomention
that the diffusion path of the dissolved drug is elongated since air-
ﬁlled voids are impermeable for the dissolution media, on the
other hand, diffusion still contributes to the release of MNZ
through the ﬂooded channels and pores (1).
Comparison of dissolution data demonstrated that the
release proﬁles of M5 and M6 can be considered similar only
(f1: 4.92 and f2: 67.87) (46) in spite of their different composition
and density (Table I), as well. Kinetic model analysis revealed
that Korsmeyer-Peppas model ﬁtted best to dissolution data
(Table III): This kinetic model is used to analyse drug release of
polymeric formulations when more than one type of release
phenomena is involved. Release exponents of M4 and M5 were
0.9414 and 0.9759 indicate Super Case-II transport due to the
cylindrical shape, while forM6 andM7, the n values were 0.7162
and 0.6889 corresponding to anomalous or non-Fickian diffu-
sion transport. According to these ﬁndings, beside the rates of
drug release, the mechanism is modiﬁed by Labrasol, as well. A
possible explanation could be that Labrasol works as a
plasticiser in the matrix; therefore, a rapid water uptake and
matrix is coupled with the increased API concentration in the
inner pores, due to the solubilisation of MNZ.
This also suggests differences in the speed of structural
weakening of the foams as seen during texture analyses.
Plasticising the PEG and SA chains together with a higher rate
of water imbibition resulted the fastest erosion of M4.
Plasticising effect could be the reason of the signiﬁcantly softer
texture of the dry M4 at 25°C. However, 10% of SAwas able to
develop a more ordered structure, resulting a harder and more
resistant matrix. SA not only delays disintegration and increases
hardness, but due to its edible nature, shows advantageous
properties as oral release retardant (47).
CONCLUSION
This study describes a novel technology developed to foam
hot and molten dispersions on atmospheric pressure. This
technology is directly applicable to produce ﬂoating, low-
density moulded dosage forms. Undissolved drug in the molten
dispersion does not affect the continuous buoyancy up to 30%.
MNZ was released mainly by the erosion of the PEG-SA
matrix; however, Labrasol as a non-ionic solubiliser alters the
dissolution mechanism by increasing drug solubility and increas-
ing the rate of water uptake. We applied several methods to
characterise the properties of foammatrix system. SEMpictures
and microCT scans conﬁrmed that air bubbles form spherical
closed-cell structure where clusters of interconnecting voids can
be found. Texture analysis conﬁrmed that SA in our matrices
inhibits disintegration and maintains mechanical resistance in
acidic buffer at 37°C. The temperature of the technology is ideal
for hard capsule ﬁlling to prolong gastric residence time.
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